Bayer is committing another €1.3 billion to Leaps by Bayer, the company’s investment arm, to support additional investments in companies developing innovative technologies in healthcare and agriculture. In addition to backing companies developing cell and gene therapies, Leaps has also deployed its cash to startups developing artificial intelligence technologies for a range of applications.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.